Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases


Sanchez G. A. M. , Reinhardt A., Ramsey S., Wittkowski H., Hashkes P. J. , Murias S., ...Daha Fazla

ARTHRITIS & RHEUMATOLOGY, cilt.69, 2017 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 69
  • Basım Tarihi: 2017
  • Dergi Adı: ARTHRITIS & RHEUMATOLOGY